Soyka, Michael

A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

Buch, S., Stickel, F., Trépo, E., Way, M., Herrmann, A., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., et al. (2015) · Nature Genetics

Alcohol Consumption and Health EffectsGenetic Associations and Epidemiology

Cited by 565

Genome‐wide significant association between alcohol dependence and a variant in the ADH gene cluster

Frank, J., Cichon, S., Treutlein, J., Ridinger, M., Mattheisen, M., Hoffmann, P., Herms, S., Wodarz, N., Soyka, M., Zill, P., et al. (2012) · Addiction Biology

Genetic Associations and EpidemiologyAlcohol Consumption and Health Effects

Cited by 176

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus

Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., Alam, F., Alho, H., Benyamina, A., Bobes, J., et al. (2017) · Expert Opinion on Pharmacotherapy

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 141

Psychopathology in dual diagnosis and non-addicted schizophrenics—are there differences

Soyka, M., Albus, M., Immler, B., Kathmann, N., & Hippius, H. (2001) · European Archives of Psychiatry and Clinical Neuroscience

Schizophrenia research and treatmentSubstance Abuse Treatment and Outcomes

Cited by 58

Treatment-refractory substance use disorder: focus on alcohol, opioids, and cocaine

Soyka, M., & Mutschler, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 49

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

Fischler, P. V., Soyka, M., Seifritz, E., & Mutschler, J. (2022) · Frontiers in Pharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 34

Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts

Bonnet, U., Specka, M., Soyka, M., Alberti, T., Bender, S., Grigoleit, T., Hermle, L., Hilger, J., Hillemacher, T., Kuhlmann, T., et al. (2020) · Frontiers in Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 29